Who are EVARREST™ Sealant Matrix's main competitors?

No direct comparators detected in our index.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/evarrest-sealant-matrix.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

EVARREST™ Sealant Matrix — Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

EVARREST™ Sealant Matrix (EVARREST™ Sealant Matrix) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Hemostatic sealant / Fibrin sealant. Area: Surgery / Hemostasis.

phase 3 Hemostatic sealant / Fibrin sealant Surgery / Hemostasis Biologic Live · refreshed every 30 min

Target snapshot

EVARREST™ Sealant Matrix (EVARREST™ Sealant Matrix) — Ethicon, Inc.. EVARREST is a hemostatic sealant matrix that combines human thrombin and fibrinogen to form a biodegradable fibrin clot at the surgical site, promoting rapid hemostasis.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target	Approval / PDUFA
EVARREST™ Sealant Matrix TARGET	EVARREST™ Sealant Matrix	Ethicon, Inc.	phase 3	Hemostatic sealant / Fibrin sealant

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Hemostatic sealant / Fibrin sealant class)

Ethicon, Inc. · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). EVARREST™ Sealant Matrix — Competitive Intelligence Brief. https://druglandscape.com/ci/evarrest-sealant-matrix. Accessed 2026-06-10.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing